SAMS Martin James,HIGH Juliet Victoria,JAMIESON Paul Andrew,BOOLES Clive
申请号:
SI201231365
公开号:
SI2793857T1
申请日:
2012.12.19
申请国别(地区):
SI
年份:
2018
代理人:
摘要:
The invention provides a pharmaceutical composition for the transmucosal delivery of a PDE5 inhibitor, said composition comprising a PDE5 inhibitor and a carrier in which said PDE5 inhibitor is soluble or forms a suspension or emulsion. The invention also provides a pharmaceutical composition comprising a PDE5 inhibitor for use in inhibiting PDE activity in vivo, where in said use said composition is delivered by the transmucosal route.